BIOVEST INTERNATIONAL
Biovest International, Inc. is a publicly-traded (OTCQB: BVTI), emerging leader in the field of active personalized immunotherapy targeting life-threatening cancers of the blood system, and markets state-of-the-art hollow fiber bio-production instruments, as well as provides custom cell culture services, including contract manufacturing.
BIOVEST INTERNATIONAL
Industry:
Biotechnology Developer Platform Health Care Therapeutics
Founded:
1981-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.biovest.com
Total Employee:
11+
Status:
Active
Contact:
813-864-2554
Email Addresses:
[email protected]
Total Funding:
7 M USD
Technology used in webpage:
Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator GoDaddy Premium DNS
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-07-30 | Biotalys | Biovest International investment in Series C - Biotalys | 35 M EUR |
| 2017-03-09 | Biotalys | Biovest International investment in Series B - Biotalys | 11.62 M USD |
| 2013-06-25 | MDxHealth | Biovest International investment in Post-IPO Equity - MDxHealth | 23.6 M USD |
Official Site Inspections
http://www.biovest.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
